Which of endoscopic submucosal dissection or surgery should be selected in patients who have early gastric cancer with a risk factor for noncurative resection?
Digestive Endoscopy · 2023
DOI: 10.1111/den.14513 ↗Kurz gefasst
Editorial in der Zeitschrift Digestive Endoscopy, 2023. Verfasst von Waku Hatta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Endoscopic Mucosal Resection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
- Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
ORCID-Profile: Waku Hatta
Zitieren
APA
Hatta, W., Gotoda, T., Koike, T., & Masamune, A. (2023). Which of endoscopic submucosal dissection or surgery should be selected in patients who have early gastric cancer with a risk factor for noncurative resection?. Digestive Endoscopy. https://doi.org/10.1111/den.14513
Vancouver
Hatta W, Gotoda T, Koike T, Masamune A. Which of endoscopic submucosal dissection or surgery should be selected in patients who have early gastric cancer with a risk factor for noncurative resection?. Digestive Endoscopy. 2023. doi:10.1111/den.14513
BibTeX
@article{Hatta2023,
author = {Hatta, Waku and Gotoda, Takuji and Koike, Tomoyuki and Masamune, Atsushi},
title = {Which of endoscopic submucosal dissection or surgery should be selected in patients who have early gastric cancer with a risk factor for noncurative resection?},
journal = {Digestive Endoscopy},
year = {2023},
doi = {10.1111/den.14513}
}
EUVIMED